Juvenile Idiopathic Arthritis clinical trials

Explore recruiting juvenile idiopathic arthritis clinical trials.

Recruiting juvenile idiopathic arthritis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Juvenile Idiopathic Arthritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

I1F-MC-RHCG: Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab with Adalimumab Reference Arm, in Children with Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Germany, Spain, France, Belgium, Czechia, Netherlands +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

I4V-MC-JAHU: Open-Label, Randomized Study with a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children from 1 to Less Than 18 Years of Age with Systemic Juvenile Idiopathic Arthritis

Belgium, Poland, Czechia, France, Austria, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Optimizing treatment for children and adolescents with Juvenile Idiopathic Arthritis in sustained remission: a comparison of three treatment strategies. An open randomized multicenter trial assessing two different treatment withdrawal strategies compared to continued stable treatment with methotrexate and tumor necrosis factor inhibitor in children and adolescents with juvenile idiopathic arthritis in stable remission. The MOVE-JIA trial

Norway

Therapeutic use (Phase IV) EU CTIS Study details

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA)

Italy, Netherlands, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics.

Belgium, Italy, Portugal, Lithuania, Spain, Denmark +1 more

Therapeutic use (Phase IV) EU CTIS Study details

A multicenter, randomized open-label study to assess the efficacy, safety, and pharmacokinetics of upadacitinib with a tocilizumab reference arm in subjects from 1 year to less than 18 years old with active systemic juvenile idiopathic arthritis.

Spain, Sweden, Germany, Belgium, Italy, Austria +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Juvenile Idiopathic Arthritis trials by city

Juvenile Idiopathic Arthritis in Toronto Juvenile Idiopathic Arthritis in Vancouver Juvenile Idiopathic Arthritis in Montreal Juvenile Idiopathic Arthritis in Calgary Juvenile Idiopathic Arthritis in Edmonton Juvenile Idiopathic Arthritis in Ottawa Juvenile Idiopathic Arthritis in Winnipeg Juvenile Idiopathic Arthritis in Quebec City Juvenile Idiopathic Arthritis in Hamilton Juvenile Idiopathic Arthritis in Kitchener Juvenile Idiopathic Arthritis in London Juvenile Idiopathic Arthritis in Halifax Juvenile Idiopathic Arthritis in New York Juvenile Idiopathic Arthritis in Los Angeles Juvenile Idiopathic Arthritis in Chicago Juvenile Idiopathic Arthritis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease